Chairman and Chief Executive Officer
Jay earned a Bachelors degree in Chemistry from St. Joseph's University (Philadelphia) in 1980, a Masters in Chemistry from SJU in 1983 and an MBA with a concentration in Finance from SJU in 1986. An alumnus of the Harvard Business School, Borneman subsequently earned his PhD from the Department of Health Policy and Public Health at the University of the Sciences in Philadelphia. His research interests are in the health policy considerations of healthcare access and Complementary and Alternative Medicine (CAM).
He is the fourth generation of his family in the business of homeopathic pharmacy and has been associated with homeopathic firms throughout his life; serving as Vice President of John A. Borneman and Sons, later Boiron-Borneman, from 1980 through 1987; and joining Standard Homeopathic Company and Hyland's, Inc. at that time. He is a principal owner of the company and also serves as CEO of Hyland's, Inc., the company's wholly owned distribution subsidiary. In addition to serving on Standard's Board, Dr. Borneman serves on the Boards of the Homoeopathic Pharmacopoeia of the United States as its President, Consumer Healthcare Products Association as Chairman of the CHPA Political Action Committee and as an emeritus director of The National Center for Homeopathy. He serves on various advisory boards including the College of Arts and Sciences at St. Joseph’s University and the National Association of Chain Drug Stores. He has chaired the Legal and Regulatory Affairs Committee of the American Association Of Homeopathic Pharmacists since 2001. He currently has a faculty appointment as Adjunct Associate Professor of Health Policy and Public Health at the University of the Sciences in Philadelphia.